← FDA Drug Approvals (Drugs@FDA)

LEGUBETI

NDA · New Drug Application · Sponsor: GALEPHAR · Approved 2024-02-13

Drug application

FDA Application #

NDA215040

Application type

New Drug Application

Brand name

LEGUBETI

Generic name

Acetylcysteine Lysine

Active ingredients

ACETYLCYSTEINE LYSINE

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

GALEPHAR

First approval

2024-02-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown